دورية أكاديمية

What Is the Optimal Bridging Therapy for Patients with Hepatitis C-associated Hepatocellular Carcinoma Awaiting Liver Transplant? An Analysis of the United States HCC Liver Transplantation Consortium

التفاصيل البيبلوغرافية
العنوان: What Is the Optimal Bridging Therapy for Patients with Hepatitis C-associated Hepatocellular Carcinoma Awaiting Liver Transplant? An Analysis of the United States HCC Liver Transplantation Consortium
المؤلفون: Medin, C., Turgeon, M., Keilson, J., Shah, S., Agopian, V., Magliocca, J., Cameron, A., Orloff, S., Kubal, C., Cannon, R., Akoad, M., Emamaullee, J., Aucejo, F., Vagefi, P., Nguyen, M., Dhanireddy, K., Kazimi, M., Sonnenday, C., Foley, D., Abouljoud, M., Sudan, D., Humar, A., Doyle, M., Chapman, W., Maithel, S.
المصدر: In HPB 2022 24 Supplement 1:S78-S78
قاعدة البيانات: ScienceDirect
الوصف
تدمد:1365182X
DOI:10.1016/j.hpb.2022.05.142